Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0RGI stock hub

LON/0RGI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RGIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RGI

In the news

Latest news · LON/0RGI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E1,058

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-0.7

P25 -54.2P50 2.1P75 13.7

ROIC-1.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RGI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

EUR

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	UK
Employees	325
Employees Change	2.7%
Employees Change Percent	0.84
Enterprise value	CHF 1B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	NL0011832936
Last refreshed	2026-05-10
Market cap	CHF 1.1B
Price	CHF 73.7
Price currency	CHF
Rev Per Employee	279,626.38x
Sector	Healthcare
Sic	2834
Symbol	lon/0RGI
Website	https://www.cosmohealthconfidence.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.28%
EV Earnings	-324.24x
EV/EBITDA	199.55x
EV/FCF	-70.1x
EV/Sales	11.15x
FCF yield	-1.3%
Forward P/E	1,058.02x
P/B ratio	2.62x
P/S ratio	12.31x
PE Ratio10 Y	1,495.72x
PE Ratio3 Y	17.29x
PE Ratio5 Y	2,925.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.66%
EBITDA Margin	4.86%
Gross margin	48.53%
Gross Profit	CHF 44.1M
Gross Profit Growth	-62.41%
Gross Profit Growth Q	-77.47%
Gross Profit Growth3 Y	-29.08%
Gross Profit Growth5 Y	-4.03%
Net Income	CHF -3.1M
Net Income Growth Years	0%
Pretax Margin	-0.88%
Profit Margin	-3.46%
Profit Per Employee	CHF -9,685
ROA	-0.69
Roa5y	3.63
ROCE	-1.18
ROE	-0.7
Roe5y	6.9
ROIC	-1.87
Roic5y	8.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	58.67%
Cagr3y	14.08%
Cagr5y	-1.25%
Div CAGR10	-2.57%
Div CAGR3	26.39%
Div CAGR5	17.51%
EPS Growth Years	0
Revenue Growth	-60.95x
Revenue Growth Q	-59.82x
Revenue Growth Years	0x
Revenue Growth3 Y	-17.48x
Revenue Growth5 Y	-0.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.17
Assets	CHF 534.4M
Cash	CHF 107.1M
Current Assets	CHF 158.5M
Current Liabilities	CHF 22.1M
Debt	CHF 3.7M
Debt EBITDA	CHF 0.73
Debt Equity	CHF 0.01
Debt FCF	CHF -0.26
Equity	CHF 426.7M
Interest Coverage	-57.8
Liabilities	CHF 107.7M
Long Term Assets	CHF 375.9M
Long Term Liabilities	CHF 85.6M
Net Cash	CHF 103.4M
Net Cash By Market Cap	CHF 9.24
Net Cash Growth	-15.82%
Net Debt EBITDA	CHF -23.41
Net Debt Equity	CHF -0.24
Tangible Book Value	CHF 264M
Tangible Book Value Per Share	CHF 16.31
WACC	12.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.18
Inventory Turnover	4.48
Net Working Capital	CHF 31.1M
Quick ratio	5.8
Working Capital	CHF 137.6M
Working Capital Turnover	CHF 0.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.73%
Dividend Growth	5.01%
Dividend Growth Years	3%
Dividend per share	CHF 1.82
Dividend Years	5
Dividend Yield	2.36%
Ex Div Date	2026-04-24
Last Dividend	CHF 1.82
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	58.62%
200-day SMA	82.8
3Y total return	48.5%
50-day SMA	91
50-day SMA vs 200-day SMA	50over200
5Y total return	-6.1%
All Time High	174
All Time High Change	-57.64%
All Time High Date	2016-05-20
All Time Low	33.75
All Time Low Change	118.37%
All Time Low Date	2023-10-27
ATR	4.46
Beta	1.48
Ch YTD	-29.94
High	78.2
High52	129.6
High52 Date	2026-02-03
High52ch	-43.13%
Low	73.19
Low52	49.4
Low52 Date	2025-05-08
Low52ch	49.19%
Ma50ch	-19.01%
Price vs 200-day SMA	-10.99%
RSI	28.18
RSI Monthly	50.16
RSI Weekly	41.65
Sharpe ratio	1.15x
Sortino ratio	2.2
Total Return	5.09%
Tr YTD	-28.48
Tr1m	-12.31%
Tr1w	-9.22%
Tr3m	-34.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF -6.1M
Operating margin	-6.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,690,932%
Net Borrowing	-982,676
Shares Institutions	22.12%
Shares Qo Q	-0.01%
Shares Yo Y	-2.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -16.8M
Average Volume	7,764.4x
Bv Per Share	25.99
CAPEX	CHF -3.7M
Ch1m	-14.1
Ch1w	-9.22
Ch1y	50.1
Ch3m	-35.58
Ch3y	33.9
Ch5y	-16.91
Ch6m	18.84
Change	-5.41%
Change From Open	-3.28
Close	77.92
Days Gap	-2.21
Depreciation Amortization	10,377,785.2
Dollar Volume	226,553.8
Earnings Date	2026-07-20
EBIT	CHF -6.1M
EBITDA	CHF 4.4M
EPS	CHF -0.2
F Score	2
FCF	CHF -14.6M
FCF EV Yield	-1.43x
Financing CF	-21,333,007
Fiscal Year End	December
Founded	1,997
Goodwill	20,765,085.7
Income Tax	CHF 2.2M
Investing CF	44,028,660
Is Primary Listing	0
Last Earnings Date	2026-03-09
Last Report Date	2025-12-31
Ma150	89.83
Ma150ch	-17.96%
Ma20	89.02
Ma20ch	-17.21%
Net CF	10,092,482
Next Earnings Date	2026-07-20
Open	76.2
Payment Date	2026-05-11
Position In Range	10.18
Ppne	26,648,166.2
Price Date	2026-05-08
Price EBITDA	CHF 253
Ptbv Ratio	4.24
Relative Volume	0.4x
Revenue	90,878,575x
SBC By Revenue	2.49x
Share Based Comp	2,265,552
Tax By Revenue	2.47x
Tr6m	21.31%
Volume	3,074
Z Score	6.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0RGI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$1.82 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.5%

3 consecutive years of growth

Total shareholder yield

+5.1%

Next ex-dividend date: 2026-04-24

Performance

LON/0RGI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RGI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.7%

Negative means the company is buying back shares.

Technical

LON/0RGI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.2

Below 30: short-term oversold

Price vs 200-day MA

-11.0%

50/200-day relationship not available

Beta (5Y)

1.48

More volatile than the market

Sharpe ratio

1.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RGI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RGI stock rating?

lon/0RGI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RGI analysis?

The full report lives at /stocks/lon/0RGI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RGI?

The latest report frames lon/0RGI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RGI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.